Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Not Confirmed
Not Confirmed
16-17 February, 2026
Not Confirmed
Not Confirmed
17-18 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Industry Trade Show
Not Confirmed
16-17 February, 2026
Industry Trade Show
Not Confirmed
17-18 February, 2026
Digital content

05 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/05/3233455/0/en/Eledon-Pharmaceuticals-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

23 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/23/3224604/0/en/Eledon-Pharmaceuticals-Presents-Long-Term-Phase-1b-Data-for-Tegoprubart-in-Kidney-Transplant-Patients-at-the-American-Society-of-Transplant-Surgeons-Winter-Symposium.html

01 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/01/3196846/0/en/Eledon-Pharmaceuticals-to-Participate-in-the-37th-Annual-Piper-Sandler-Healthcare-Conference.html

18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3190482/0/en/Eledon-Reports-Preliminary-Data-from-First-Six-Patients-with-Type-1-Diabetes-Treated-with-Tegoprubart-as-the-Core-Immunosuppressant-Following-Islet-Transplantation-in-Investigator-.html

14 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/14/3188645/0/en/Eledon-Pharmaceuticals-Announces-Recent-Business-Highlights-and-Third-Quarter-2025-Financial-Results.html

12 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/12/3186141/0/en/Eledon-Pharmaceuticals-Announces-Pricing-of-50-Million-Underwritten-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
ABOUT THIS PAGE